Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy
- PMID: 16565362
- DOI: 10.1167/iovs.05-1292
Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy
Abstract
Purpose: To examine the effect of a short course of high-dose retinol (preformed vitamin A) on dark adaptation in older adults with normal retinal health or early age-related maculopathy (ARM).
Methods: The study design was a randomized, double-masked, placebo-controlled experiment. Adults > or = 50 years of age whose fundus photographs for the eye to be tested psychophysically fell within steps 1 to 9 of the Age-Related Eye Disease Study (AREDS) Grading System were randomly assigned to a 30-day course of 50,000 IU oral retinol or a placebo. At baseline and 30-day follow-up, dark adaptation was tested and the Low Luminance Questionnaire (LLQ), an instrument for assessing difficulty with vision in reduced lighting, was administered. Primary outcomes of interest were rod- and cone-mediated parameters of dark adaptation, with scores on the LLQ's six subscales as secondary outcomes.
Results: The sample consisted of 104 participants with 52 each in the intervention and placebo groups. There were no group differences in baseline variables. At 30-days, the dark-adaptation parameters of cone time-constant, cone threshold, rod-cone break, and rod threshold did not differ. The retinol intervention group had significantly larger (i.e., steeper) rod slopes, indicating faster sensitivity recovery, than did the placebo group (P = 0.0419). There were no group differences in scores on the LLQ subscales driving, extreme lighting, emotional distress, general lighting, or peripheral vision. The retinol group had a higher score by five points on the mobility subscale compared with the placebo group (P = 0.0141). Those who had the most self-reported change on the mobility subscale at day 30 were more likely to have greater change in the speed of dark adaptation, as indicated by the rod slope parameter (r = 0.24, P = 0.0141).
Conclusions: A short-term, high-dose course of retinol increased the rate of rod-mediated dark adaptation in older adults who were in the early phases of ARM or were exhibiting normal retinal aging. These results are consistent with the hypothesis that depositions and other structural changes in the retinal pigment epithelium and Bruch's membrane in aging and early ARM cause a localized retinoid deficiency.
Similar articles
-
Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.Ophthalmology. 2007 Sep;114(9):1728-35. doi: 10.1016/j.ophtha.2006.12.023. Ophthalmology. 2007. PMID: 17822978
-
Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy.Invest Ophthalmol Vis Sci. 2006 Feb;47(2):528-35. doi: 10.1167/iovs.05-1222. Invest Ophthalmol Vis Sci. 2006. PMID: 16431946
-
Measuring rod and cone dynamics in age-related maculopathy.Invest Ophthalmol Vis Sci. 2008 Jan;49(1):55-65. doi: 10.1167/iovs.06-1048. Invest Ophthalmol Vis Sci. 2008. PMID: 18172075
-
Photoreceptor degeneration and dysfunction in aging and age-related maculopathy.Ageing Res Rev. 2002 Jun;1(3):381-96. doi: 10.1016/s1568-1637(02)00007-7. Ageing Res Rev. 2002. PMID: 12067593 Review.
-
Spare the rods, save the cones in aging and age-related maculopathy.Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2015-8. Invest Ophthalmol Vis Sci. 2000. PMID: 10892836 Review. No abstract available.
Cited by
-
The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.Ophthalmology. 2019 Apr;126(4):591-600. doi: 10.1016/j.ophtha.2018.10.037. Epub 2018 Oct 31. Ophthalmology. 2019. PMID: 30389424 Free PMC article.
-
The impact of diabetic retinopathy on quality of life: qualitative findings from an item bank development project.Qual Life Res. 2012 Dec;21(10):1771-82. doi: 10.1007/s11136-012-0110-1. Qual Life Res. 2012. PMID: 22290480
-
Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.Ann Med. 2006;38(7):450-71. doi: 10.1080/07853890600946724. Ann Med. 2006. PMID: 17101537 Free PMC article. Review.
-
Aging and vision.Vision Res. 2011 Jul 1;51(13):1610-22. doi: 10.1016/j.visres.2010.10.020. Epub 2010 Oct 23. Vision Res. 2011. PMID: 20974168 Free PMC article. Review.
-
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254. doi: 10.1002/14651858.CD000254.pub5. Cochrane Database Syst Rev. 2023. PMID: 37702300 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical